<DOC>
	<DOCNO>NCT02330692</DOCNO>
	<brief_summary>Developing molecular genetic test identify prognostic factor predict response treatment , contribute establishment future therapeutic strategy base prognostic factor undergo peripheral blood bone marrow examination Myelodysplastic Syndrome ( MDS ) patient diagnosis relapse .</brief_summary>
	<brief_title>Cohort Study New Prognostic Factors With Peripheral Blood Bone Marrow Evaluation Time Diagnosis Relapse Myelodysplastic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>MDS diagnose bone marrow aspiration biopsy Severance Hospital . Male Female 16 year age . ③ Written consent patient participate cohort ④ Deaths study period waiver consent ① Refusal trouble understand write consent</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>